Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6‐month follow‐up – The SOLO study
暂无分享,去创建一个
Mathias Maier | C. Meyer | L. Hattenbach | C. Clemens | N. Feltgen | Nicolas Feltgen | Carsten H Meyer | M. Maier | G. Spital | J. Wachtlin | Athanasios Bezatis | Georg Spital | Fabian Höhn | Christoph R Clemens | Joachim Wachtlin | Florian Lehmann | Lars Olof Hattenbach | A. Bezatis | F. Höhn | F. Lehmann | L. Hattenbach | Carsten H. Meyer
[1] E. Stefánsson,et al. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. , 2001, Acta ophthalmologica Scandinavica.
[2] P. Szurman,et al. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[3] H. Agostini,et al. [Intravitreal drug therapy for retinal vein occlusion--pathophysiological mechanisms and routinely used drugs]. , 2010, Klinische Monatsblatter fur Augenheilkunde.
[4] H. Ackermann,et al. Combination therapy in diabetic macular oedema and retinal vein occlusion – past and present , 2012, Acta ophthalmologica.
[5] S. Mennel,et al. The vitreomacular interface in retinal vein occlusion , 2011, Acta ophthalmologica.
[6] S. Mennel,et al. Radial Optic Neurotomy for Central Retinal Vein Occlusion: Long-Term Retinal Perfusion Outcome , 2009, Ophthalmologica.
[7] M. Blumenkranz,et al. Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion , 2011, Clinical ophthalmology.
[8] Sarah Gray,et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.
[9] C. Meyer,et al. RELEASE AND VELOCITY OF MICRONIZED DEXAMETHASONE IMPLANTS WITH AN INTRAVITREAL DRUG DELIVERY SYSTEM: Kinematic Analysis With a High-Speed Camera , 2012, Retina.
[10] I. Scott,et al. SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. , 2009, Ophthalmology.
[11] P. Campochiaro,et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.
[12] M. Parodi,et al. Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting , 2012, Acta ophthalmologica.
[13] Osamu Sawada,et al. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion , 2013, Acta ophthalmologica.
[14] Ronald Klein,et al. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. , 2008, Archives of ophthalmology.
[15] Ingrid U Scott,et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.
[16] M. Blumenkranz,et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.
[17] R. Ritch,et al. Association of exfoliation syndrome and central retinal vein occlusion: an ultrastructural analysis , 2010, Acta ophthalmologica.
[18] G. Soubrane,et al. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes , 2009, Acta ophthalmologica.
[19] S. Mennel,et al. Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections , 2011, Acta ophthalmologica.
[20] L. Hattenbach,et al. Ophthalmologische Diagnostik und Bildgebung bei venösen retinalen Gefäßverschlüssen , 2011, Der Ophthalmologe.
[21] Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. , 1986, Archives of ophthalmology.
[22] M. Maia,et al. Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection. , 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[23] Tien Yin Wong,et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. , 2010, Ophthalmology.
[24] Monika Fleckenstein,et al. Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high‐resolution, spectral‐domain optical coherence tomography , 2010, Acta ophthalmologica.